ZNZhannat M. Nurmakhanova

Zhannat M. Nurmakhanova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhannat M. Nurmakhanova has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Predictors of Autism Spectrum Disorders Development (Review of the Current State of the Problem)

    by K. R. Rustemova, R. R. Tuhvatshin, Zh. M. Nurmakhanova, K. K. Isaeva, Ch. B. Baktybekova, M. V. Fazulyanova, E. A. Ogorodnikova

    This review presents data from current research aimed at understanding the causes and risk factors for autism spectrum disorders (ASDs), which encompasses a wide range of neurodevelopmental disorders with unclear etiologies. The relevance of this problem stems from the increasing prevalence of ASDs, the lack of a unifying theory of its etiopathogenesis, the polymorphism of its clinical forms, and the difficulty of diagnosing and treating this group of disorders. In this context, an important area of research is the analysis of the biological, medical, and behavioral aspects of ASD manifestations, as well as the search for predictors of autism development early in development and the development of multifactor and multidisciplinary models based on these predictors, drawing on advances in genomics, neurophysiology, neuroimaging, and artificial intelligence. The review materials may be useful to a wide range of specialists (physiology, medicine, psychology, special education) in developing strategies for the prevention and diagnosis of ASDs using innovative biomedical and digital technologies, personalized practical recommendations for supporting children with ASDs, and also serve as a basis for further fundamental and applied research on autism.

  • The problem of low detection of autism spectrum disorders in Kazakhatan

    by Z. Yessimbekova, Z. Nurmakhanova

    This article examines the identification of autism spectrum disorders (ASD)in young children using the M-CHAT screening questionnaire in primary care settings. The aim is to evaluate the characteristics and limitations of early detection of autism spectrum disorders in young children using the standardized M-CHAT screening test. The study determined the prevalence of positive ASD screening results among young children and analyzed the main challenges and barriers to the implementation and use of M-CHAT by primary care physicians. To analyze detection issues, parental inquiries and discussion on online forums and social media dedicated to developmental delays and autism spectrum were analyzed. Based on the data obtained, practical recommendations were developed an algorithm for optimizing ASD screening in a clinic setting was proposed, aimed at increasing the effectiveness of early detection and improving patient routing.

  • Open Access

    Prevalence of smoking and use of nicotine-containing products among medical students and physicians in CIS countries: a cross-sectional study

    by Oksana M. Drapkina, Oleg O. Salagay, Ruslan N. Shepel, Olga Yu. Kuznetsova, Ekaterina D. Savchenko, Elena A. Andreeva, Anna V. Turusheva, Marina A. Pokhaznikova, Gulbanu Z. Abdugulova, Akmaral B. Abdykulova, et al.

    BACKGROUND: To implement effective measures to reduce smoking and the use of novel nicotine-containing products among medical students and physicians, objective national-level data on smoking behavior are required. AIM: This work aimed to assess the prevalence of smoking and use of nicotine-containing products among medical students and primary care physicians in the CIS. METHODS: A cross-sectional consent-based survey was conducted. An online questionnaire administered via an electronic platform was used to assess the type of products consumed, frequency and duration of use, age of initiation, attempts to quit smoking, exposure to passive smoking, awareness of nicotine-related health risks, and availability of smoking cessation programs. RESULTS: The study included 9222 students and 1599 physicians from five countries. The prevalence of smoking among students and physicians, respectively, was: Russia 20.3% and 17.1%; Belarus 17.0% and 18.3%; Kyrgyzstan 15.4% and 6.8%; Kazakhstan 8.2% and 12.8%; Uzbekistan 3.2% and 5.9%. Smoking prevalence among women was lower than among men in all countries (p 0.05), except among students in Belarus (p 0.05). The prevalence of nicotine-containing product use (including combined use with conventional cigarettes) did not differ between men and women among students in most countries, except in Kyrgyzstan (p 0.05). The primary risk factors for smoking among students, regardless of country, were smoking by friends and smoking by classmates or dormitory roommates. Among physicians, 3.7%–12.5% of men and 10%–50% of women who reported quitting tobacco continued to use electronic cigarettes. Male physicians were more frequently exposed to passive smoking at work, whereas female physicians were more frequently exposed at home. Attitudes of healthcare professionals toward tobacco products and electronic cigarettes remarkably influenced the likelihood of using specific forms of smoking. CONCLUSION: This study expands current data on the prevalence of smoking, including passive smoking, as well as on cross-country similarities and differences in smoking behavior and smoking-related risk factors among healthcare professionals.


  • Open Access

    Changes in Mental and Physical Status and Potential Treatment for Patients with Post-COVID-19 Chronic Heart Failure

    by Zhannat M. Nurmakhanova, Zulfiya M. Zhankalova, Gulbanu Z. Abdugulova, Akmaral B. Abdykulova, Gulzhan H. Gabdulina, Aigul E. Tazhieva, Venera B. Khabizhanova, Indira S. Omarova, Zoya Zh. Ensegenova, Elmira R. Yerenchina, et al.

    BACKGROUND: Coronavirus infection can negatively impact the mental and physical status of patients with chronic heart failure, exacerbating anxiety and depressive symptoms. These changes should be recognized and addressed promptly. AIM: The study aimed to evaluate the impact of COVID-19 on the mental and physical status of patients with chronic heart failure who were eligible for treatment in primary care settings. METHODS: The study included patients with chronic heart failure of various origins with or without a history of COVID-19. The physical and mental health of all patients was evaluated using three scales: the Sheehan Patient-Rated Anxiety Scale, the Beck Depression Inventory, and the Social Adaptation Self-Evaluation Scale. Eligible patients with COVID-19 were prescribed sertraline, a selective serotonin reuptake inhibitor antidepressant, based on results of a psychometric evaluation. RESULTS: Sertraline is shown to significantly improve anxiety disorder, particularly severe cases, in patients with chronic heart failure who have recovered from COVID-19. Sertraline was found to be even more clinically effective in the treatment of depression; it improved depressive symptoms in all study groups. Sertraline was found to affect cardiovascular parameters in patients with chronic heart failure after COVID-19. Sertraline decreased heart rate, thereby improving the course of chronic heart failure. In addition, the ejection fraction remained virtually unchanged in the short term, which indicates the efficacy and safety of sertraline. This supports the recommendation to add sertraline to the combined therapy for this patient group. CONCLUSION: The study confirms the significant impact of COVID-19 on the physical and mental status of patients with chronic heart failure. However, the agents used to treat these conditions may affect the cardiovascular system. Patients require a comprehensive treatment strategy that includes support for mental and physical health.

  • Open Access

    Difficulties of management of a pregnant patient with renal carbuncles

    by Dauren Zhantleu, Zhannat Nurmakhanova, Daniyar Sultankulov

    Massive antibiotic therapy, even with the most powerful modern drugs, does not lead to a cure for the disease with a carbuncle of the kidney without opening and draining the purulent-necrotic focus. Establishing the diagnosis of carbuncle of the kidney provides for urgent surgical intervention.